Insulin resistance and abdominal obesity are increasingly viewed as chronic inflammatory conditions, leading to the production of a wide variety of pro-inflammatory cytokines and chemokines, including IL-6, monocyte chemoattractant protein-1, TNF-α and other inflammatory factors [76–78]. The gene discussed is CCL2; the disease is Insulin resistance.